This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Click to access and download your KEYNOTE-048 slide deck

Prescribing Information

Download this slide deck for information on KEYNOTE 048.

More information about KEYTRUDA® (pembrolizumab) in first-line Head & Neck Squamous Cell Carcinoma:

Supporting documentation

GB-OHN-00172 | Date of Preparation: June 2020